nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—Blister—Mechlorethamine—lymphatic system cancer	0.0533	0.0533	CcSEcCtD
Cyclizine—Altered state of consciousness—Vincristine—lymphatic system cancer	0.033	0.033	CcSEcCtD
Cyclizine—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.0322	0.0322	CcSEcCtD
Cyclizine—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.0292	0.0292	CcSEcCtD
Cyclizine—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0235	0.0235	CcSEcCtD
Cyclizine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0201	0.0201	CcSEcCtD
Cyclizine—Speech disorder—Carmustine—lymphatic system cancer	0.0185	0.0185	CcSEcCtD
Cyclizine—Bronchospasm—Teniposide—lymphatic system cancer	0.0175	0.0175	CcSEcCtD
Cyclizine—Injection site reaction—Carmustine—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Cyclizine—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Cyclizine—Disorientation—Bleomycin—lymphatic system cancer	0.0148	0.0148	CcSEcCtD
Cyclizine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Cyclizine—Thrombophlebitis—Carmustine—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Cyclizine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Cyclizine—Chills—Teniposide—lymphatic system cancer	0.0128	0.0128	CcSEcCtD
Cyclizine—Agitation—Teniposide—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Cyclizine—Bronchospasm—Bleomycin—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Cyclizine—Chills—Fludarabine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Cyclizine—Hypertension—Teniposide—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Cyclizine—Urinary retention—Vincristine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Cyclizine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Cyclizine—Agitation—Fludarabine—lymphatic system cancer	0.01	0.01	CcSEcCtD
Cyclizine—Tachycardia—Teniposide—lymphatic system cancer	0.00987	0.00987	CcSEcCtD
Cyclizine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00971	0.00971	CcSEcCtD
Cyclizine—Hypotension—Teniposide—lymphatic system cancer	0.00945	0.00945	CcSEcCtD
Cyclizine—Convulsion—Fludarabine—lymphatic system cancer	0.00944	0.00944	CcSEcCtD
Cyclizine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00889	0.00889	CcSEcCtD
Cyclizine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00872	0.00872	CcSEcCtD
Cyclizine—Apnoea—Methotrexate—lymphatic system cancer	0.00871	0.00871	CcSEcCtD
Cyclizine—Speech disorder—Methotrexate—lymphatic system cancer	0.00859	0.00859	CcSEcCtD
Cyclizine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00829	0.00829	CcSEcCtD
Cyclizine—Chills—Bleomycin—lymphatic system cancer	0.00823	0.00823	CcSEcCtD
Cyclizine—Urticaria—Teniposide—lymphatic system cancer	0.00803	0.00803	CcSEcCtD
Cyclizine—Erythema—Bleomycin—lymphatic system cancer	0.00799	0.00799	CcSEcCtD
Cyclizine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00798	0.00798	CcSEcCtD
Cyclizine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00787	0.00787	CcSEcCtD
Cyclizine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00774	0.00774	CcSEcCtD
Cyclizine—Constipation—Fludarabine—lymphatic system cancer	0.0076	0.0076	CcSEcCtD
Cyclizine—Pain—Fludarabine—lymphatic system cancer	0.0076	0.0076	CcSEcCtD
Cyclizine—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00751	0.00751	CcSEcCtD
Cyclizine—Eye disorder—Carmustine—lymphatic system cancer	0.00748	0.00748	CcSEcCtD
Cyclizine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00745	0.00745	CcSEcCtD
Cyclizine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Cyclizine—Asthenia—Teniposide—lymphatic system cancer	0.00726	0.00726	CcSEcCtD
Cyclizine—Pruritus—Teniposide—lymphatic system cancer	0.00716	0.00716	CcSEcCtD
Cyclizine—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00713	0.00713	CcSEcCtD
Cyclizine—Mental disorder—Carmustine—lymphatic system cancer	0.00702	0.00702	CcSEcCtD
Cyclizine—Erythema—Carmustine—lymphatic system cancer	0.00697	0.00697	CcSEcCtD
Cyclizine—Mental disorder—Vincristine—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Cyclizine—Chills—Mitoxantrone—lymphatic system cancer	0.00668	0.00668	CcSEcCtD
Cyclizine—Vision blurred—Carmustine—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Cyclizine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00655	0.00655	CcSEcCtD
Cyclizine—Tremor—Carmustine—lymphatic system cancer	0.00653	0.00653	CcSEcCtD
Cyclizine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Cyclizine—Erythema—Mitoxantrone—lymphatic system cancer	0.00648	0.00648	CcSEcCtD
Cyclizine—Agitation—Carmustine—lymphatic system cancer	0.00641	0.00641	CcSEcCtD
Cyclizine—Asthenia—Fludarabine—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Cyclizine—Headache—Teniposide—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Cyclizine—Pruritus—Fludarabine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Cyclizine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00619	0.00619	CcSEcCtD
Cyclizine—Agitation—Vincristine—lymphatic system cancer	0.00612	0.00612	CcSEcCtD
Cyclizine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Cyclizine—Hypotension—Bleomycin—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Cyclizine—Convulsion—Carmustine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Cyclizine—Hypertension—Carmustine—lymphatic system cancer	0.00602	0.00602	CcSEcCtD
Cyclizine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00585	0.00585	CcSEcCtD
Cyclizine—Convulsion—Vincristine—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Cyclizine—Hypertension—Vincristine—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Cyclizine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Cyclizine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Cyclizine—Pain—Bleomycin—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Cyclizine—Headache—Fludarabine—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Cyclizine—Tachycardia—Carmustine—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Cyclizine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Cyclizine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Cyclizine—Hypotension—Carmustine—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Cyclizine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00529	0.00529	CcSEcCtD
Cyclizine—Urticaria—Bleomycin—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Cyclizine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Cyclizine—Insomnia—Carmustine—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Cyclizine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Cyclizine—Paraesthesia—Carmustine—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Cyclizine—Hypotension—Vincristine—lymphatic system cancer	0.00507	0.00507	CcSEcCtD
Cyclizine—Somnolence—Carmustine—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Cyclizine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00494	0.00494	CcSEcCtD
Cyclizine—Insomnia—Vincristine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Cyclizine—Paraesthesia—Vincristine—lymphatic system cancer	0.00488	0.00488	CcSEcCtD
Cyclizine—Constipation—Carmustine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Cyclizine—Pain—Carmustine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Cyclizine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Cyclizine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Cyclizine—Somnolence—Mitoxantrone—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Cyclizine—Asthenia—Bleomycin—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Cyclizine—Pain—Vincristine—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Cyclizine—Constipation—Vincristine—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Cyclizine—Pruritus—Bleomycin—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Cyclizine—Constipation—Mitoxantrone—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Cyclizine—Pain—Mitoxantrone—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Cyclizine—Urticaria—Mitoxantrone—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Cyclizine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Cyclizine—Drowsiness—Methotrexate—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Cyclizine—Asthenia—Carmustine—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Cyclizine—Hypersensitivity—Vincristine—lymphatic system cancer	0.004	0.004	CcSEcCtD
Cyclizine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Cyclizine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Cyclizine—Asthenia—Vincristine—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Cyclizine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Cyclizine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Cyclizine—Dizziness—Carmustine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Cyclizine—Hepatitis—Methotrexate—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Cyclizine—Dizziness—Vincristine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Cyclizine—Headache—Carmustine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Cyclizine—Eye disorder—Methotrexate—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Cyclizine—Headache—Vincristine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Cyclizine—Chills—Methotrexate—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Cyclizine—Headache—Mitoxantrone—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Cyclizine—Mental disorder—Methotrexate—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Cyclizine—Erythema—Methotrexate—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Cyclizine—Vision blurred—Methotrexate—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Cyclizine—Convulsion—Methotrexate—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Cyclizine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Cyclizine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Cyclizine—Skin disorder—Methotrexate—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Cyclizine—Hypotension—Methotrexate—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Cyclizine—Insomnia—Methotrexate—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Cyclizine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Cyclizine—Somnolence—Methotrexate—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Cyclizine—Pain—Methotrexate—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Cyclizine—Urticaria—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Cyclizine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Cyclizine—Asthenia—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Cyclizine—Pruritus—Methotrexate—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Cyclizine—Dizziness—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Cyclizine—Headache—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
